Center for Genomic Interpretation (EIN 820918164) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2017

Legal Domicile

Principal Officer

Julie M Eggington

Phone

8018104097

Tax Period

2022-01-01 to 2022-12-31

Center for Genomic Interpretation, founded in 2017, is a small nonprofit in the Education sector that reported $267K in total revenue in fiscal year 2022. Revenue decreased 6% compared to the prior year. Expenses of $338K exceeded revenue, resulting in a 27% operating deficit.

Mission

The mission of the Organization is to build an expertly curated, comprehensive human genetic variant database that, once established, will significantly contribute to the scientific research findings that will be published and made available to the public. Through our work we will identify genetic markers of disease, which is the first step to identifying cures for both hereditary and somatic diseases.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $176,916

Program Service Revenue $89,690

Investment Income $315

Other Revenue $0

TOTAL REVENUE $266,921

Expense Breakdown

Grants Paid $0

Salaries & Benefits $230,206

Fundraising Expenses $0

Program Expenses $303,277

Other Expenses $107,481

TOTAL EXPENSES $337,687

Year-over-Year Comparison

	2022	2021	Change
Revenue	$266,921	$284,425	-0.1%
Expenses	$337,687	$324,248	+0.0%
Net Income	$-70,766	$-39,823	+0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$31,200

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Julie M Eggington	CEO	50.00	Officer	$31,200	$0	$31,200

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$266,921	$337,687	$367,901	$-70,766
2021	$284,425	$324,248	$441,519	$-39,823
2019	$273,713	$260,847	$82,211	$12,866
2018	$205,337	$144,293	$69,413	$61,044

Center for Genomic Interpretation